About this event:

Date: October 17, 2023

Time: 11 am EST | 8 am PST |

4 pm GMT | 5 pm CET

Duration: 30 minutes

Recent years have witnessed a rapid increase in early phase clinical trials and successful regulatory approvals for multiple AAV-based therapies utilizing diverse serotypes. Amidst the pursuit of delivering novel, high quality, and safe AAV products, the importance of an efficient, scalable, and platformable purification process for a variety of AAV serotypes is paramount for both pharmaceutical developers and contract development and manufacturing organizations (CDMOs).

This webinar investigates the critical considerations when assessing an affinity capture step within a comprehensive AAV vector purification strategy. Parameters such as specificity, binding capacity, purity, yield, scalability, and reusability will be thoroughly examined. We will also share performance data of the industry-leading Thermo Scientific^TM POROS^TM CaptureSelect^TM AAV affinity resin in relation to other commercially available options.

Key Takeaways:

• Crucial factors for choosing the appropriate affinity capture step for an AAV purification process. 
  
  
• Comprehensive performance data, including dynamic binding capacity comparisons between POROS^TM CaptureSelect^TM AAV affinity resin and other AAV purification resins. 
  
  
• Insights from resin reuse studies, contributing to a reduced cost of goods for AAV production.